Omega 3 Fatty Acids: Novel Neurotherapeutic Targets for Cognitive Dysfunction in Mood Disorders and Schizophrenia?

E-ISSN： 1875-6190|13|5|663-680

ISSN： 1570-159X

Source： Current Neuropharmacology, Vol.13, Iss.5, 2015-09, pp. : 663-680

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Omega-3 Fatty Acids in the Treatment of Psychiatric Disorders

By Peet Malcolm Stokes Caroline

Drugs, Vol. 65, Iss. 8, 2005-01 ,pp. : 1051-1059

Adis International

Access to resources Recommend Favorite

Clinical Potential of Omega-3 Fatty Acids in the Treatment of Schizophrenia

By Emsley R.

CNS Drugs, Vol. 17, Iss. 15, 2003-01 ,pp. : 1081-1091

Adis International

Access to resources Recommend Favorite

Omega-3 Fatty Acids Supplementation in Psychiatric Disorders: A Systematic Review

By Bellino Silvio Bozzatello Paola Brignolo Elena Brunetti Chiara Bogetto Filippo

Current Psychopharmacology, Vol. 1, Iss. 4, 2012-11 ,pp. : 353-364

Bentham Science Publishers

Access to resources Recommend Favorite

Omega-3 Fatty Acids Supplementation in Psychiatric Disorders: A Systematic Review

Current Psychopharmacology, Vol. 1, Iss. 4, 2012-11 ,pp. : 353-364

Bentham Science Publishers

Access to resources Recommend Favorite

Supplementation of Glutamine and Omega-3 Polyunsaturated Fatty Acids as a Novel Therapeutic Intervention Targeting Metabolic Dysfunction and Exercise Intolerance in Patients with Heart Failure

Current Clinical Pharmacology, Vol. 6, Iss. 4, 2011-11 ,pp. : 288-294

Bentham Science Publishers

Access to resources Recommend Favorite